FOX RUN MANAGEMENT, L.L.C.

Position in RPRX — Royalty Pharma plc

CIK 1533457 GREENWICH, CT

Position in RPRX

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$897,758

+$255,049 QoQ

Shares Held

18,715

-9.4% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2021

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

FOX RUN MANAGEMENT, L.L.C. holds $18,757,602 across 55 Biotechnology names. RPRX ranks #1 (4.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc This page	18,715	$897,758
2	NUVL	Nuvalent, Inc.	8,173	$837,323
3	RARE	Ultragenyx Pharmaceutical Inc.	37,136	$777,999
4	HALO	Halozyme Therapeutics, Inc.	10,778	$696,582
5	SLNO	Soleno Therapeutics Inc	19,934	$667,390
6	ADMA	Adma Biologics, Inc.	73,991	$666,658
7	ONC	BeOne Medicines Ltd.	2,136	$634,327
8	ELVN	Enliven Therapeutics, Inc.	15,573	$610,461

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$897,758	18,715	-9.4%	Shares	Sole	2026-05-12
2025-03-31	$642,709	20,646	-62.5%	Shares	Sole	2025-05-13
2024-12-31	$1,404,631	55,062	+41.3%	Shares	Sole	2025-02-11
2024-09-30	$1,102,687	38,978	+3.7%	Shares	Sole	2024-11-12
2024-06-30	$991,380	37,595	+49.9%	Shares	Sole	2024-08-13
2024-03-31	$761,892	25,087	+223.7%	Shares	Sole	2024-05-13
2023-06-30	$238,235	7,750	-67.0%	Shares	Sole	2023-08-11
2023-03-31	$845,011	23,453	+146.0%	Shares	Sole	2023-05-12
2022-12-31	$376,783	9,534	-35.5%	Shares	Sole	2023-02-07
2022-03-31	$576,101	14,787	+70.8%	Shares	Sole	2022-05-10
2021-09-30	$312,936	8,659	—	Shares	Sole	2021-11-15
No filing history on record for this holder in this stock.